Galderma’s main focus is to ensure that customer’s needs are met using high service standards for existing, as well as new products. A constant priority is strict compliance with worldwide standards in quality, safety and environment, and we take pride in the fact that these are an integral part of our everyday work. The Manufacturing & Technical Operations teams manage all the supply activities, including purchasing and plant and contractor supply chain leadership. We strive to maintain optimal performance, while encouraging employees to be innovative in every area.
To deliver products offering the best quality, cost and service benefits the company’s manufacturing capacity is spread across the following sites. The French and Canadian plants have been extended in order to optimize and increase production capacity and ensure best-in-class standards for quality, safety and the environment. In 2011, the four sites have produced over 100 million units.
Laboratoires Galderma SAS
Zone Industrielle - Touvière
74540 Alby sur Chéran - France
Phone: +33 (0)1 58 86 45 45 - Fax: +33 (0)4 50 68 31 33
With a workforce of 200, the company’s French site has an annual production capacity of 30 million units. It manufactures the liquid and semi-liquid forms of products on five platforms and eight production lines and supplies over sixty countries in Europe, the Middle East, Africa, Australia, Asia and South America. The site has received ISO 14001 and OHSAS 18001 certifications and has been certified by several Health Agencies.
Galderma’s fifty-strong Industrial Development team is also based at the Alby-sur-Chéran site in the French Alps. The unit develops and improves manufacturing processes for new products, acquisitions and transfers, and supplies reference raw materials. It also produces clinical batches for trials worldwide. Industrial Development is tasked with leveraging Galderma’s technical process.
Visiting address: Fyrisvallsgatan 7
75228 Uppsala - Sweden
Phone: +46 18 474 90 00 - Fax: +46 18 474 90 01
The site in Uppsala, Sweden is the Global Aesthetic Center of Excellence with nearly 400 employees as well as world-class research and manufacturing. The site is responsible for Innovation, Development, Manufacturing and Strategic brand management for aesthetic and corrective treatments. A majority of the products in the Q-Med portfolio is based on the company’s patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid.
The manufacturing site employs 170 people and has served the market worldwide with leading brands like Restylane and Macrolane since 1996.
Galderma Production Canada Inc.
19400 Route Trans-Canada Hwy
Baie d'Urfé, Québec
H9X 3S4 - Canada
Phone: +1 514 457 33 66 - Fax: +1 514 457 83 99
Employing 220 people, Galderma’s Canadian site, near to Montreal, has seven manufacturing platforms and eight packaging lines offering a combined annual production capacity of 45 to 50 million units. Liquid and semi-liquid forms are manufactured here: pharmaceutical products for the US market and non-prescription products for all the markets worldwide. The plant is ISO 14001, OHSAS 18001 as well as FDA, ANVISA and Santé Canada certified.
Galderma Brasil Ltda.
Rodovia SP 101 - Campinas-Monte Mor, Km 9
Condominio Techtown - CEP 13186-904
Hortolândia-SP - Brazil
Phone: +55 19 3045 6900 - Fax: +55 19 3845 5261
The Brazilian site came on stream in November 2004 and today employs about 35 people. Specializing in liquid and paste forms, it offers an annual production capacity of 5 million units. Products manufactured here are shipped throughout Brazil and other Latin American countries.